US Patent 7192698 EphA2 as a diagnostic target for metastatic cancer
Patent 7192698 was granted and assigned to Purdue Research Foundation on March, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 7 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+359 characters)
Article
Patent abstract
Method and kits are provided for the detection and diagnosis of metastatic disease. More particularly, the methods and kits employ compounds that can detect EphA2, a specific epithelial cell tyrosine kinase that is overexpressed in metastatic tumor cells. In one embodiment the compound is an antibody capable of binding to an epitope of EphA2.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07192698 EphA2 as a diagnostic target for metastatic cancer US Patent 7192698 EphA2 as a diagnostic target for metastatic cancer
Infobox
Patent Number
0719269800
Patent Number
719269800
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071926980
Date of Patent
March 20, 2007
0Patent Application Number
096409520
Date Filed
August 17, 2000
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071926980
Date of Patent
March 20, 2007
0Patent Application Number
096409520
Date Filed
August 17, 2000
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07192698 EphA2 as a diagnostic target for metastatic cancer
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07192698
Date of patent
March 20, 2007
Patent application number
09640952
Date Filed
August 17, 2000
Patent primary examiner
Find more entities like US Patent 7192698 EphA2 as a diagnostic target for metastatic cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
